Xeljanz and Pain - a phase IV clinical study of FDA data
Pain is found among people who take Xeljanz, especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months.
The phase IV clinical study analyzes which people take Xeljanz and have Pain. It is created by eHealthMe based on reports of 192,294 people who have side effects when taking Xeljanz from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
192,294 people reported to have side effects when taking Xeljanz.
Among them, 26,984 people (14.03%) have Pain.
What is Xeljanz?
Xeljanz has active ingredients of tofacitinib citrate. It is often used in rheumatoid arthritis. eHealthMe is studying from 222,435 Xeljanz users for its effectiveness, alternative drugs and more.
What is Pain?
Pain is found to be associated with 5,320 drugs and 5,716 conditions by eHealthMe.
Number of Xeljanz and Pain reports submitted per year:
Time on Xeljanz when people have Pain *:
Gender of people who have Pain when taking Xeljanz*:
Age of people who have Pain when taking Xeljanz *:
Common drugs people take besides Xeljanz *:
Common side effects people have besides Pain *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Xeljanz and have Pain?Check whether Pain is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Pain and when was it recovered:
Expand to all the drugs that have ingredients of tofacitinib citrate:
- Pain and drugs with ingredients of tofacitinib citrate (27,567 reports)
Alternative drugs to, pros and cons of Xeljanz:
- Xeljanz (222,435 reports)
Common Xeljanz side effects:
- Drug ineffective: 48,562 reports
- Pain: 26,984 reports
- Joint pain: 25,292 reports
- Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints): 20,971 reports
- Fatigue (feeling of tiredness): 16,775 reports
- Headache (pain in head): 16,267 reports
- Joint swelling: 15,442 reports
- Malaise (a feeling of general discomfort or uneasiness): 13,828 reports
- Diarrhea: 12,636 reports
Browse all side effects of Xeljanz:a b c d e f g h i j k l m n o p q r s t u v w x y z
Pain treatments and more:
- Pain (1,088,462 reports)
COVID vaccines that are related to Pain:
- Pain in Moderna COVID Vaccine
- Pain in Pfizer BioNTech Covid Vaccine
- Pain in Johnson and Johnson Covid Vaccine
Common drugs associated with Pain:
- Oxycontin: 55,550 reports
- Enbrel: 47,830 reports
- Humira: 47,288 reports
- Methotrexate: 44,785 reports
- Prednisone: 43,232 reports
- Lyrica: 30,908 reports
- Xeljanz: 26,984 reports
- Oxycodone: 24,129 reports
- Aspirin: 22,287 reports
- Actemra: 20,065 reports
All the drugs that are associated with Pain:
- Pain (5,320 drugs)
Common conditions associated with Pain:
- Rheumatoid arthritis: 88,017 reports
- Multiple sclerosis: 29,170 reports
- High blood pressure: 19,549 reports
All the conditions that are associated with Pain:
- Pain (5,716 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on tofacitinib citrate (the active ingredients of Xeljanz) and Xeljanz (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Symbicort and Dyspnea Exacerbated - 6 seconds ago
- Aspirin and Troponin Increased - 8 seconds ago
- Prednisone and Troponin Increased - 8 seconds ago
- Ageusia and drugs of ingredients of furosemide - 11 seconds ago
- Doxycycline Hyclate and Carboplatin drug interaction - 11 seconds ago
- Clozapine and Troponin Increased - 22 seconds ago
- Olux and Stress And Anxiety - 22 seconds ago
- Humatrope and Dexedrine drug interaction - 23 seconds ago
- Ortho Tri-Cyclen and Liver Function Test Abnormal - 25 seconds ago
- Coenzyme Q10 and Pregabalin drug interaction - 27 seconds ago